세계의 말초 신경염 치료 시장 보고서(2025년)

Peripheral Neuritis Treatment Global Market Report 2025

US $ 4,490 ￦ 6,319,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,134,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,949,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

말초 신경염 치료제 시장 규모는 향후 몇 년 동안 큰 폭의 성장을 보일 것으로 예상됩니다. 예측 기간의 성장은 치료 옵션의 범위 확대, 노인 인구 증가, 비만율 증가, HIV/AIDS 유병률, 제네릭 의약품 시장의 성장, 정부 및 의료 이니셔티브에 기인한 것으로 볼 수 있습니다. 이 기간 동안의 주요 트렌드에는 협업 및 파트너십, 기술 발전, 당뇨병성 말초 신경염 치료 제품 출시 증가, 개인 맞춤형 의약품에 대한 관심 증대, 비약물적 치료법 개발, 디지털 건강 도구의 통합 등이 포함됩니다.

당뇨병 유병률의 증가는 말초 신경염 치료 시장의 확대를 견인할 것으로 예상됩니다. 당뇨병은 혈당(포도당) 수치를 적절하게 조절하는 신체의 능력에 영향을 미치는 만성 질환입니다. 당뇨병 발병률의 증가는 앉아서 생활하는 생활 습관, 건강에 해로운 식단, 비만, 인구 고령화, 유전적 소인 등의 요인에 기인할 수 있습니다. 말초 신경염 치료는 신경 통증을 완화하고 염증을 줄이며 신경 기능을 강화하여 삶의 질을 개선하고 합병증을 예방함으로써 당뇨병 환자를 지원하는 데 중요한 역할을 합니다. 예를 들어, 2023년 11월 미국의 비영리 단체인 미국당뇨병협회는 2022년에 미국에서 약 2,550만 명이 당뇨병 진단을 받았으며, 이는 전체 인구의 7.6%에 해당한다고 보고했습니다. 따라서 당뇨병 유병률의 증가는 말초 신경염 치료 시장의 성장을 촉진하고 있습니다.

말초 신경염 치료 시장을 선도하는 기업들은 신경 재생을 촉진하고 신경병증성 통증을 완화하기 위해 자기 말초 신경 자극(mPNS)과 같은 혁신적인 치료법을 개발하는 데 주력하고 있습니다. 자기 말초 신경 자극은 자기장을 이용해 말초 신경을 자극하는 비침습적 신경 조절 기술로, 신경병증 및 근골격계 질환의 통증 관리, 신경 재생, 운동 기능 개선에 도움을 줍니다. 예를 들어, 2024년 1월, 미국에 본사를 둔 의료 장비 제조업체인 Neuralace Medical Inc.는 만성 통증성 당뇨병성 신경병증(PDN) 치료를 위한 Axon Therapy(mPNS)에 대한 FDA 승인을 발표했습니다. 이 치료법은 통증 완화를 위한 빠르고 통증이 없는 비침습적 접근 방식을 제공합니다. 임상시험에서 30일째 72.3%의 반응률과 90일째 81.4%의 반응률을 보여 통증과 무감각 감소에 효과가 있음을 입증했습니다. 이번 승인은 통증 관리의 중요한 진전을 의미하며, 환자에게 약물 부작용 없이 기존 치료법을 대체할 수 있는 대안을 제공합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 말초 신경염 치료 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업의 분석
• 세계의 말초 신경염 치료 시장 : 성장률 분석
• 세계의 말초 신경염 치료 시장 실적 : 규모와 성장(2019-2024년)
• 세계의 말초 신경염 치료 시장 예측 : 규모와 성장(2024-2029년, 2034년)
• 세계의 말초 신경염 치료 총 시장 규모(TAM)

제6장 시장 세분화

• 세계의 말초 신경염 치료 시장 : 치료 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 약리학적 치료
• 비약물치료
• 세계의 말초 신경염 치료 시장 : 약물 등급별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 항우울제
• 항경련제
• 국소 마취
• 진통제
• 스테로이드
• 기타
• 세계의 말초 신경염 치료 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 병원 약국
• 소매 약국
• 온라인 약국
• 드럭 스토어
• 세계의 말초 신경염 치료 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 당뇨병성 말초 신경염
• 화학치료 유발성 말초 신경염
• 특발성 말초 신경염
• 기타
• 세계의 말초 신경염 치료 시장 : 약물 치료 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 진통제
• 항우울제
• 항경련제
• 국소 약물
• 세계의 말초 신경염 치료 시장 : 비약물 치료 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 물리치료
• 경피적 전기신경자극(TENS)
• 침술
• 라이프 스타일과 식단 개선

제7장 지역별 및 국가별 분석

• 세계의 말초 신경염 치료 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 세계의 말초 신경염 치료 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

• 말초 신경염 치료 시장 : 경쟁 구도
• 말초 신경염 치료 시장 : 기업 프로파일
  • Pfizer Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
  • Johnson & Johnson(J&J)개요, 제품 및 서비스, 전략 및 재무 분석
  • AstraZeneca Plc 개요, 제품 및 서비스, 전략 및 재무 분석
  • Novartis AG 개요, 제품 및 서비스, 전략 및 재무 분석
  • GSK plc 개요, 제품 및 서비스, 전략 및 재무 분석

제31장 기타 주요 기업 및 혁신 기업

• Takeda Pharmaceuticals & Co. Ltd.
• Eli Lilly and Co.
• Mallinckrodt Pharmaceuticals plc
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• Astellas Pharma Inc.
• Sun Pharmaceutical Industries Ltd.
• Apotex Inc.
• Dr Reddys Laboratories Ltd.
• Cipla Inc.
• Amneal Pharmaceuticals LLC
• Lupin Ltd.
• Daiichi Sankyo Co. Ltd.
• Glenmark Pharmaceuticals Ltd.
• Cadila Pharmaceuticals Ltd.

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

• 말초 신경염 치료 시장(2029년) : 새로운 기회를 제공하는 국가
• 말초 신경염 치료 시장(2029년) : 새로운 기회를 제공하는 부문
• 말초 신경염 치료 시장(2029년) : 성장 전략
  • 시장 동향에 기초한 전략
  • 경쟁 전략

제36장 부록

HBR

영문 목차

영문목차

Peripheral neuritis is characterized by inflammation or damage to the peripheral nerves, resulting in symptoms such as pain, weakness, numbness, and tingling. It is commonly caused by factors such as diabetes, infections, toxins, or nutritional deficiencies. Treatment options include medications, physical therapy, lifestyle adjustments, and addressing underlying conditions.

The primary treatment approaches for peripheral neuritis include pharmacological and non-pharmacological therapies. Pharmacological treatments involve the use of medications such as pain relievers, anticonvulsants, and antidepressants to alleviate pain and enhance nerve function. These medications are categorized into antidepressants, anticonvulsants, local anesthetics, analgesics, steroids, and other drug classes. They are distributed through various channels, including hospital pharmacies, retail pharmacies, online pharmacies, and drug stores. These treatments are applied to conditions such as diabetic peripheral neuropathy, chemotherapy-induced peripheral neuropathy, idiopathic peripheral neuropathy, and others.

The peripheral neuritis treatment market research report is one of a series of new reports from The Business Research Company that provides peripheral neuritis treatment market statistics, including the peripheral neuritis treatment industry global market size, regional shares, competitors with the peripheral neuritis treatment market share, detailed peripheral neuritis treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the peripheral neuritis treatment industry. This peripheral neuritis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The peripheral neuritis treatment market size has grown strongly in recent years. It will grow from $1.84 billion in 2024 to $1.93 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth during the historic period can be attributed to rising healthcare expenditure, an increase in chronic diseases, the growing prevalence of conditions linked to peripheral neuritis, a higher rate of diabetes, and a growing aging population.

The peripheral neuritis treatment market size is expected to see strong growth in the next few years. It will grow to $2.36 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to the expanding range of treatment options, a rising geriatric population, increasing obesity rates, the prevalence of HIV/AIDS, the growth of the generic drug market, and government and healthcare initiatives. Key trends during this period include collaborations and partnerships, technological advancements, an increase in diabetic peripheral neuritis treatment product launches, a heightened focus on personalized medicine, the development of non-pharmacological therapies, and the integration of digital health tools.

The increasing prevalence of diabetes is expected to drive the expansion of the peripheral neuritis treatment market. Diabetes is a chronic condition that affects the body's ability to regulate blood sugar (glucose) levels properly. The rising incidence of diabetes can be attributed to factors such as sedentary lifestyles, unhealthy diets, obesity, aging populations, and genetic predisposition. Peripheral neuritis treatment plays a crucial role in supporting diabetic individuals by alleviating nerve pain, reducing inflammation, and enhancing nerve function, thereby improving quality of life and preventing complications. For example, in November 2023, the American Diabetes Association, a US-based non-profit organization, reported that approximately 25.5 million people in the U.S. were diagnosed with diabetes in 2022, representing 7.6% of the total population. Consequently, the increasing prevalence of diabetes is fueling the growth of the peripheral neuritis treatment market.

Leading companies in the peripheral neuritis treatment market are focusing on developing innovative treatments, such as magnetic peripheral nerve stimulation (mPNS), to promote nerve regeneration and alleviate neuropathic pain. Magnetic peripheral nerve stimulation is a non-invasive neuromodulation technique that uses magnetic fields to stimulate peripheral nerves, aiding in pain management, nerve regeneration, and motor function improvement in conditions such as neuropathy and musculoskeletal disorders. For instance, in January 2024, Neuralace Medical Inc., a US-based medical equipment manufacturer, announced FDA approval for Axon Therapy (mPNS) for the treatment of chronic painful diabetic neuropathy (PDN). This therapy offers a quick, painless, and non-invasive approach to pain relief. Clinical trials demonstrated a 72.3% responder rate at Day 30 and an 81.4% responder rate at Day 90, underscoring its effectiveness in reducing pain and numbness. This approval represents a significant advancement in pain management, providing patients with an alternative to traditional treatments without the side effects of medication.

In October 2024, Alkem Laboratories Limited, an India-based pharmaceutical company, partnered with Sonnet BioTherapeutics to develop, manufacture, and commercialize SON-080, a drug candidate for treating diabetic peripheral neuropathy (DPN) in India. Sonnet BioTherapeutics is a US-based biotechnology company specializing in oncology.

Major players in the peripheral neuritis treatment market are Pfizer Inc., Johnson & Johnson (J&J), AstraZeneca Plc, Novartis AG, GSK plc, Takeda Pharmaceuticals & Co. Ltd., Eli Lilly and Co., Mallinckrodt Pharmaceuticals plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Sun Pharmaceutical Industries Ltd., Apotex Inc., Dr Reddys Laboratories Ltd., Cipla Inc., Amneal Pharmaceuticals LLC, Lupin Ltd., Daiichi Sankyo Co. Ltd., Glenmark Pharmaceuticals Ltd., Cadila Pharmaceuticals Ltd.

North America was the largest region in the peripheral neuritis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in peripheral neuritis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the peripheral neuritis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The peripheral neuritis treatment market consists of revenues earned by entities by providing services such as pharmacological treatment, physical therapy and rehabilitation, nutritional and dietary support, lifestyle management and patient education. The market value includes the value of related goods sold by the service provider or included within the service offering. The peripheral neuritis treatment market also includes sales of pain relievers, antidepressants, anticonvulsants, and corticosteroids. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Peripheral Neuritis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on peripheral neuritis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for peripheral neuritis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The peripheral neuritis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Pharmacological Therapies; Non Pharmacological Therapies
• 2) By Drug Class: Anti-Depressants; Anticonvulsants; Local Anesthesia; Analgesics; Steroids; Other Drug Classes
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Drug Stores
• 4) By Application: Diabetic Peripheral Neuropathy; Chemotherapy-Induced Peripheral Neuropathy; Idiopathic Peripheral Neuropathy; Other Applications
• Subsegments:
• 1) By Pharmacological Therapies: Pain Relievers (Analgesics); Antidepressants; Anticonvulsants; Topical Medications
• 2) By Non-Pharmacological Therapies: Physical Therapy; Transcutaneous Electrical Nerve Stimulation (TENS); Acupuncture; Lifestyle And Dietary Modifications
• Companies Mentioned:Pfizer Inc.; Johnson & Johnson (J&J); AstraZeneca Plc; Novartis AG; GSK plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Peripheral Neuritis Treatment Market Characteristics

3. Peripheral Neuritis Treatment Market Trends And Strategies

4. Peripheral Neuritis Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Peripheral Neuritis Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Peripheral Neuritis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Peripheral Neuritis Treatment Market Growth Rate Analysis
• 5.4. Global Peripheral Neuritis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Peripheral Neuritis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Peripheral Neuritis Treatment Total Addressable Market (TAM)

6. Peripheral Neuritis Treatment Market Segmentation

• 6.1. Global Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmacological Therapies
• Non Pharmacological Therapies
• 6.2. Global Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anti-Depressants
• Anticonvulsants
• Local Anesthesia
• Analgesics
• Steroids
• Other Drug Classes
• 6.3. Global Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Drug Stores
• 6.4. Global Peripheral Neuritis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diabetic Peripheral Neuropathy
• Chemotherapy-Induced Peripheral Neuropathy
• Idiopathic Peripheral Neuropathy
• Other Applications
• 6.5. Global Peripheral Neuritis Treatment Market, Sub-Segmentation Of Pharmacological Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pain Relievers (Analgesics)
• Antidepressants
• Anticonvulsants
• Topical Medications
• 6.6. Global Peripheral Neuritis Treatment Market, Sub-Segmentation Of Non-Pharmacological Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Physical Therapy
• Transcutaneous Electrical Nerve Stimulation (TENS)
• Acupuncture
• Lifestyle And Dietary Modifications

7. Peripheral Neuritis Treatment Market Regional And Country Analysis

• 7.1. Global Peripheral Neuritis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Peripheral Neuritis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Peripheral Neuritis Treatment Market

• 8.1. Asia-Pacific Peripheral Neuritis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Peripheral Neuritis Treatment Market

• 9.1. China Peripheral Neuritis Treatment Market Overview
• 9.2. China Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Peripheral Neuritis Treatment Market

• 10.1. India Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Peripheral Neuritis Treatment Market

• 11.1. Japan Peripheral Neuritis Treatment Market Overview
• 11.2. Japan Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Peripheral Neuritis Treatment Market

• 12.1. Australia Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Peripheral Neuritis Treatment Market

• 13.1. Indonesia Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Peripheral Neuritis Treatment Market

• 14.1. South Korea Peripheral Neuritis Treatment Market Overview
• 14.2. South Korea Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Peripheral Neuritis Treatment Market

• 15.1. Western Europe Peripheral Neuritis Treatment Market Overview
• 15.2. Western Europe Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Peripheral Neuritis Treatment Market

• 16.1. UK Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Peripheral Neuritis Treatment Market

• 17.1. Germany Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Peripheral Neuritis Treatment Market

• 18.1. France Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Peripheral Neuritis Treatment Market

• 19.1. Italy Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Peripheral Neuritis Treatment Market

• 20.1. Spain Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Peripheral Neuritis Treatment Market

• 21.1. Eastern Europe Peripheral Neuritis Treatment Market Overview
• 21.2. Eastern Europe Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Peripheral Neuritis Treatment Market

• 22.1. Russia Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Peripheral Neuritis Treatment Market

• 23.1. North America Peripheral Neuritis Treatment Market Overview
• 23.2. North America Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Peripheral Neuritis Treatment Market

• 24.1. USA Peripheral Neuritis Treatment Market Overview
• 24.2. USA Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Peripheral Neuritis Treatment Market

• 25.1. Canada Peripheral Neuritis Treatment Market Overview
• 25.2. Canada Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Peripheral Neuritis Treatment Market

• 26.1. South America Peripheral Neuritis Treatment Market Overview
• 26.2. South America Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Peripheral Neuritis Treatment Market

• 27.1. Brazil Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Peripheral Neuritis Treatment Market

• 28.1. Middle East Peripheral Neuritis Treatment Market Overview
• 28.2. Middle East Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Peripheral Neuritis Treatment Market

• 29.1. Africa Peripheral Neuritis Treatment Market Overview
• 29.2. Africa Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Peripheral Neuritis Treatment Market Competitive Landscape And Company Profiles

• 30.1. Peripheral Neuritis Treatment Market Competitive Landscape
• 30.2. Peripheral Neuritis Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson (J&J) Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. GSK plc Overview, Products and Services, Strategy and Financial Analysis

31. Peripheral Neuritis Treatment Market Other Major And Innovative Companies

• 31.1. Takeda Pharmaceuticals & Co. Ltd.
• 31.2. Eli Lilly and Co.
• 31.3. Mallinckrodt Pharmaceuticals plc
• 31.4. Viatris Inc.
• 31.5. Teva Pharmaceutical Industries Ltd.
• 31.6. Astellas Pharma Inc.
• 31.7. Sun Pharmaceutical Industries Ltd.
• 31.8. Apotex Inc.
• 31.9. Dr Reddys Laboratories Ltd.
• 31.10. Cipla Inc.
• 31.11. Amneal Pharmaceuticals LLC
• 31.12. Lupin Ltd.
• 31.13. Daiichi Sankyo Co. Ltd.
• 31.14. Glenmark Pharmaceuticals Ltd.
• 31.15. Cadila Pharmaceuticals Ltd.

32. Global Peripheral Neuritis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Peripheral Neuritis Treatment Market

34. Recent Developments In The Peripheral Neuritis Treatment Market

35. Peripheral Neuritis Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Peripheral Neuritis Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Peripheral Neuritis Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Peripheral Neuritis Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료